Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Living PlatformTSE:7091 -0.57%71 PS Ratio is 0.25 as of Jul. 19, 2026, which is 47% below its 10-year median of 0.47. GuruFocus rates TSE:7091 with a GF Score™ of 71/100 and a GF Value™ of 円1,417.65 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Living Platform ranks better than 91.68% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Living Platform's share price is 円1212.00.
Living Platform's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円4,924.10. Hence, Living Platform's PS Ratio for today is 0.25.
The historical rank and industry rank for Living Platform's PS Ratio or its related term are showing as below:
TSE:7091'
s PS Ratio Range Over the Past 10 Years
Min: 0.2 Med: 0.47 Max: 1.51
Current: 0.25
During the past 9 years, Living Platform's highest PS Ratio was 1.51. The lowest was 0.20. And the median was 0.47.
TSE:7091's PS Ratio is ranked better than 91.68% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs TSE:7091: 0.25
During the past 12 months, the average Revenue per Share Growth Rate of Living Platform was 14.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 17.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 19.30% per year.
During the past 9 years, Living Platform's highest 3-Year average Revenue per Share Growth Rate was 22.40% per year. The lowest was 15.90% per year. And the median was 17.45% per year.
Back to Basics: PS Ratio
Living Platform (TSE:7091) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Living Platform PS Ratio Related Terms
Living Platform PS Ratio Historical Data
* Premium members only.
The historical data trend for Living Platform's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Living Platform's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Living Platform PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Living Platform's PS Ratio distribution charts can be found below:
* The bar in red indicates where Living Platform's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Living Platform's Share Price of today is 円1212.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Living Platform's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円4,924.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Living Platform (TSE:7091) has a PS Ratio of 0.25 as of Jul. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Living Platform and its competitors. This is 47% below median its historical median of 0.47. Over the past decade, Living Platform's PS Ratio has ranged from 0.20 to 1.51. According to the industry distribution chart, Living Platform ranks #55 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 8.3%.
Is Living Platform's PS Ratio too high?
Living Platform's current PS Ratio of 0.25 is 47% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 1.51. The Healthcare Providers & Services industry median PS Ratio is 1.52. Living Platform's value of 0.25 is 83.6% below this industry median. Based on the distribution chart, Living Platform ranks #55 out of 661 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Living Platform has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Living Platform's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Living Platform ranks #55 out of 661 companies for PS Ratio. This places Living Platform in the top 8% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.52. Living Platform's value of 0.25 is 83.6% below this benchmark. Historically, Living Platform's own PS Ratio has ranged from 0.20 to 1.51 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 1.52, Living Platform has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Living Platform's current PS Ratio of 0.25 is 83.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Living Platform and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Living Platform's current PS Ratio is 0.25, which is 47% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Living Platform stock overvalued right now?
Based on GuruFocus' analysis, Living Platform (TSE:7091) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,417.65, compared to a current price of 円1,212.00 — trading 14.5% below its estimated fair value. The current PS Ratio is 0.25, which is 47% below median its 10-year median of 0.47 and 83.6% below the Healthcare Providers & Services industry median of 1.52. Living Platform's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Living Platform (TSE:7091), the current PS Ratio is 0.25 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Living Platform (TSE:7091) Overvalued in 2026?
Based on GuruFocus' analysis, Living Platform stock appears to be undervalued.
The current stock price of 円1,212.00 is trading 14.5% below its estimated GF Value™ of 円1,417.65.
GuruFocus considers Living Platform to be Modestly Undervalued.
Key valuation signals for TSE:7091:
PS Ratio: 0.25 (47% below median its 10-year median of 0.47)
GF Value™: 円1,417.65 vs. price of 円1,212.00 (14.5% below fair value)
Industry Position: 83.6% below the Healthcare Providers & Services median (#55 of 661)
No single metric tells the full story. See the TSE:7091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Living Platform Ltd is engaged in providing nursing care, childcare, and support for people with disabilities. The company's services include paid nursing home care, Elderly housing with service, Visiting care, Regular patrol, ad hoc care nurs, ing care, Home-visit nursing, Home care support, Small multifunctional home care, among others. The Group operates in a single segment, the Life Care Business.
71GF Score
Get the complete analysis for TSE:7091
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7091 has been successfully added to your 
